PRFX
PRF Technologies Ltd.
プレマーケットデータ（自動更新なし）RVOL 0.0xDV $19,66620日平均DV $438,531?
52W high -94.3%52W low +8.2%Fwd PER 0.1xMarket cap $80,532Avg volume 443K
Company Overview
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel.
Earnings & Financials
Earnings actuals
| Period | EPS | Revenue | FCF |
|---|
| 2025 Q4 | -7.47 | $17,000 | -$4M |
| 2025 Q3 | -1.45 | $8,500 | -$987,500 |
| 2025 Q2 | -13.75 | $0 | -$991,000 |
| 2025 Q1 | -13.75 | $0 | -$991,000 |
| 2024 Q4 | -15.00 | $0 | -$2M |
| 2024 Q3 | -15.00 | $0 | -$2M |
|
